Invention Grant
- Patent Title: Method to homogenize parvovirus B19 in clinical samples
-
Application No.: US16348046Application Date: 2019-01-25
-
Publication No.: US11242571B2Publication Date: 2022-02-08
- Inventor: Kui Gao , Jeffrey M. Linnen
- Applicant: Grifols Diagnostic Solutions Inc.
- Applicant Address: US CA Emeryville
- Assignee: Grifols Diagnostic Solutions Inc.
- Current Assignee: Grifols Diagnostic Solutions Inc.
- Current Assignee Address: US CA Emeryville
- Agency: Dinsmore & Shohl LLP
- International Application: PCT/IB2019/050618 WO 20190125
- International Announcement: WO2019/145900 WO 20190801
- Main IPC: C12Q1/70
- IPC: C12Q1/70 ; C12N7/00

Abstract:
Various aspects of the invention relate to compositions and methods of analyzing blood plasma, blood serum, and manufacturing pools of plasma-derived products wherein an anionic surfactant is added to an aliquot of the blood plasma, blood serum, or manufacturing pool prior to analysis, and the counterion of the anionic surfactant is not sodium ion. The anionic surfactant may be, for example, lauryl sulfate. The counterion of the anionic surfactant may be, for example, lithium ion.
Public/Granted literature
- US20210115523A1 A METHOD TO HOMOGENIZE PARVOVIRUS B19 IN CLINICAL SAMPLES Public/Granted day:2021-04-22
Information query